The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.100.5.633

Fatal catatonia is considered a complication to the usual schizophrenic course. The syndrome may occur in cases of apparent health or show itself as an exacerbation during any form of schizophrenia. The heredobiologic and pathophysiologic mechanisms, and the clinical course prove that this syndrome does not represent a separate schizophrenic group but merely a complication.

The symptoms are: A prodromal phase which lasts from 2 weeks to a few months and shows the usual schizophrenic pattern.

First Phase.—Increasing perplexity and intense anxiety; incoherence; extreme restlessness; a "blind drive for annihilation" and suicidal tendencies; acrocyanosis, increased blood-pressure.

Second Phase.—Motor restlessness changing to a more primitive pattern; consciousness becomes increasingly clouded; unusual hematopoietic changes of the blood; blood pressure falls; pulse is rapid and weak; pupils are dilated and react sluggishly to light; reflexes are decreased; high elevation of temperature; pronounced cyanosis; petechial hemorrhages into the tissue; sudden respiratory death or vasomotor collapse.

Autopsy Findings.—Negative except for petechial hemorrhages into the tissues, and transformation of the fatty bone marrow to the erythropoietic state.

A theory of possible "asthenic metabolic changes" due to disturbances in the hormonal-vegetative system, and its practical application were discussed.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.